PUBLISHER: Grand View Research | PRODUCT CODE: 2089767
PUBLISHER: Grand View Research | PRODUCT CODE: 2089767
The global injection pen market size was valued at USD 42.5 billion in 2025 and is projected to grow from USD 45.3 billion in 2026 to USD 76.4 billion by 2033, at a CAGR of 7.7% from 2026 to 2033. North America injection pen industry held the largest share of 44.8% of the global market in 2025. A rising number of chronic diseases, such as osteoporosis, diabetes, cardiovascular disease, and multiple sclerosis, are driving the demand for injection pens.
Injector pens are ideal for chronic conditions that require frequent dosing. Another factor propelling the market is the growing utilization of innovative reusable injection pens and the growing demand for automated injection pens. Medical practitioners are turning to automated injection pens owing to their safety, simplicity, convenience, and accuracy in administering medication. A growing number of diabetic patients and their seriousness worldwide has necessitated the demand for insulin injections. For instance, according to the Institute for Health Metrics and Evaluation, over 500 million individuals globally have diabetes, impacting people of all ages and genders in every nation. This number is expected to surpass 1.3 billion in the next three decades, with diabetes becoming one of the top 10 causes of death and disability, with a current global prevalence rate of 6.1%. Moreover, sales of insulin injection pens for treating type 2 diabetes have surpassed sales of insulin vials, according to the National Institutes of Health (NIH). Injection devices are commonly utilized to self-administer insulin injections for diabetes treatment daily. Patients prefer using a pen injection method rather than a syringe to administer insulin from a vial because it is simpler. As a result, the growing occurrence of diabetes within the population has led to a rise in the use of injection pens.
The demand for injection pens has also surged due to the rising incidence of autoimmune diseases such as rheumatoid arthritis. The global prevalence of rheumatoid arthritis is approximately 0.5-1%, with biologic drugs requiring subcutaneous administration driving the adoption of injection pens. Similarly, growth hormone deficiencies, which require frequent injections, have contributed to market expansion, with pens offering better dosing accuracy and reduced administration discomfort.
Technological advancements are revolutionizing the market. Features such as dose memory, variable dosing, and ergonomic designs are enhancing patient adherence and convenience. For instance, in May 2024, the launch of Metoject Subcutaneous Injection Pen in Japan by Eisai Co., Ltd. and Nippon Medac Co., Ltd., a subsidiary of medac GmbH. This self-administrable methotrexate (MTX) pen for rheumatoid arthritis is the first of its kind in Japan. It aims to reduce patient burden and enhance the safety of self-injection. The product, available in varying dosages, received manufacturing and marketing approval in February 2024 and was added to Japan's National Health Insurance Drug Price List. With 700,000-800,000 patients with rheumatoid arthritis in Japan, this innovative pen addresses a critical therapeutic need.
The industry is witnessing significant regional expansion, driven by rising healthcare awareness and increasing prevalence of chronic diseases. In January 2024, Brazilian biopharmaceutical company Cristalia introduced a reusable pen injector for its biosimilar growth hormone, developed in collaboration with Nemera. Such partnerships highlight the focus on localized solutions to address specific market needs. In addition, rising investments in emerging markets, advancements in drug-delivery technologies, and demand for patient-friendly devices are fueling regional growth.
Global Injection Pen Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global injection pen market report based on product, application, end use, and region: